Loading patent…
AssigneesUlsan National Institute of Science and Technology, Konkuk University Glocal Industry-Academic Collaboration Foundation
InventorsJa Hyoung RYU, Sang Pil KIM, Do Hyun KIM, Hye Won CHUNG, Jae Byoung CHAE
Estimating the term…
The present disclosure relates to a pharmaceutical composition for treating retinal diseases, including a mitochondria-targeting compound as an active ingredient, wherein according to one aspect, the compound or a pharmaceutically acceptable salt thereof, and a pharmaceutical composition comprising the same may specifically induce apoptosis of senescent cells, and thus be usefully applied for the effective prevention or treatment of aging-related diseases.
A method for preventing or treating a retinal disease, comprising administering a compound represented by Formula 1 or a pharmaceutically acceptable salt thereof to a subject in need thereof:
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
A method for increasing oxygen consumption rate (OCR) of retina and RPE cells in the subject, comprising administering a compound represented by Formula 1 or a pharmaceutically acceptable salt thereof:
Dependencies are inferred from the claim text.